Key Highlights
- Wells Fargo elevated OSCR from Underweight to Equal Weight, pushing the price target from $11 to $20
- Shares are hovering around $20.50, reflecting a 43% gain so far this year
- In Florida, Oscar’s largest market representing approximately 64% of premium income, enrollment declined 13.5% year-over-year while medical loss ratios improved by 370 basis points
- First quarter 2026 earnings per share reached $2.07, significantly exceeding the $1.06 consensus forecast
- Wall Street sentiment is improving for 2026, though long-term clarity remains limited
Oscar Health (OSCR) experienced a significant rally on Wednesday following Wells Fargo’s decision to upgrade the healthcare insurer and substantially increase its valuation target, propelling shares upward by approximately 14% during the trading session.
Wells Fargo’s Stephen Baxter elevated OSCR from an Underweight rating to Equal Weight while simultaneously boosting his price objective to $20 from the previous $11 target. At the time of the rating change, the stock was hovering near $20.50.
The upgrade follows Wells Fargo’s analysis of statutory regulatory documents, which revealed that membership enrollment and health risk patterns within the insurance exchanges are performing above expectations heading into 2026.
The broader insurance sector is demonstrating significant progress in medical loss ratio performance, with companies adopting more prudent approaches to risk adjustment accounting compared to the prior year — a development Wells Fargo interprets favorably.
Baxter indicated the firm has gained confidence regarding the exchange marketplace direction for 2026, while acknowledging that forecasting beyond that timeframe continues to be challenging. Payment integrity initiatives will remain under close observation.
Performance in the Florida Market
Florida represents Oscar’s primary geographic market, generating approximately 64% of the company’s premium revenue. While membership in the state contracted by 13.5% compared to the previous year, the medical loss ratio showed substantial improvement of 370 basis points during the same timeframe.
Wells Fargo identified approximately 640 basis points of conservative positioning in Oscar’s risk adjustment methodology for Florida — a marked contrast to the approach taken in the previous year.
Entering Wednesday’s session, Oscar had already accumulated gains of 43% year-to-date, with shares positioned near $20.50 before the upgrade announcement provided additional momentum.
Despite the strong rally, trading activity showed some volatility throughout the day. Market participants appeared to be balancing concerns about uncertain long-term prospects against the encouraging developments in the near term.
Quarterly Performance and Executive Transition
Oscar Health delivered first quarter 2026 earnings of $2.07 per share, nearly doubling the Wall Street consensus estimate of $1.06. Revenue figures, however, fell short of analyst projections for the same quarter.
Analyst forecasts suggest Oscar Health will achieve full-year profitability in 2026, with three analysts recently increasing their earnings projections for the company.
On the executive side, co-founder Mario Schlosser transitioned away from his operational positions as President of Technology and Chief Technology Officer. He has assumed a new role as Co-Founder and Advisor to the CEO, where he’ll focus on the company’s artificial intelligence initiatives and digital healthcare strategies while maintaining his board membership.
The company currently commands a market capitalization of approximately $6.37 billion. Daily trading volume typically averages around 7.16 million shares.
Wells Fargo’s rating enhancement reflects a broader shift among analysts adopting more optimistic views on Oscar’s immediate prospects, driven by encouraging early 2026 exchange market indicators.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
